In this regard, one of the main pitfalls of this panel is the absence of some important genes such as NUTD15, MTHFR, and CEP72, as they are related to drug metabolism and response in new therapeutic protocols in ALL (Maamari et al., 2020). This evidence concerns the gene CEP72 and acute lymphoblastic leukemia.